Abstract
Human host genetic factors have been suggested to be determinants of the prevalence and clinical forms of Chagas disease. In this regard, IL-17A is believed to control parasitemia and protect against heart disease. In this work, we assessed whether IL17A gene polymorphisms are related to infection and/or development of the cardiac form of Chagas disease by genotyping for five IL17A SNPs (rs4711998, rs8193036, rs3819024, rs2275913 and rs7747909) in 1171 individuals from a Colombian region endemic for Chagas disease, classified as seronegative (n=595), seropositive asymptomatic (n=175) and chronic Chagas cardiomyopathy (n=401). Our results showed that SNP rs8193036, which is located upstream of the coding region of the gene, was slightly associated with protection against T. cruzi infection (P=0.0170, PFDR=0.0851, odds ratio (OR)=0.80, confidence interval (CI)=0.66–0.96) and associated with protection against the development of cardiomyopathy (P=0.0065, PFDR=0.0324, OR=0.75, CI=0.60–0.92). This finding suggests that this IL17A polymorphism could be associated with Trypanosoma cruzi infection and the development of chronic cardiomyopathy due to differential expression of cytokine IL-17A.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 digital issues and online access to articles
$119.00 per year
only $19.83 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
PAHO Washington DC Chagas Disease (American Trypanosomiasis). Regional Office for the Americas of the World Health Organization: USA, 2014.
Junqueira C, Caetano B, Bartholomeu DC, Melo MB, Ropert C, Rodrigues MM et al. The endless race between Trypanosoma cruzi and host immunity: lessons for and beyond Chagas disease. Expert Rev Mol Med 2010; 12: e29.
Andrade DV, Gollob KJ, Dutra WO . Acute chagas disease: new global challenges for an old neglected disease. PLoS Negl Trop Dis 2014; 8: e3010.
Vasconcelos RH, Montenegro SM, Azevedo EA, Gomes YM, Morais CN . Genetic susceptibility to chronic Chagas disease: an overview of single nucleotide polymorphisms of cytokine genes. Cytokine 2012; 59: 203–208.
Henao-Martinez AF, Schwartz DA, Yang IV . Chagasic cardiomyopathy, from acute to chronic: is this mediated by host susceptibility factors? Trans R Soc Trop Med Hyg 2012; 106: 521–527.
Pissetti CW, Correia D, de Oliveira RF, Llaguno MM, Balarin MA, Silva-Grecco RL et al. Genetic and functional role of TNF-alpha in the development Trypanosoma cruzi infection. PLoS Negl Trop Dis 2011; 5: e976.
Rodriguez-Perez JM, Cruz-Robles D, Hernandez-Pacheco G, Perez-Hernandez N, Murguia LE, Granados J et al. Tumor necrosis factor-alpha promoter polymorphism in Mexican patients with Chagas' disease. Immunol Lett 2005; 98: 97–102.
Ramasawmy R, Fae KC, Cunha-Neto E, Muller NG, Cavalcanti VL, Ferreira RC et al. Polymorphisms in the gene for lymphotoxin-alpha predispose to chronic Chagas cardiomyopathy. The J Infect Dis 2007; 196: 1836–1843.
Nogueira LG, Frade AF, Ianni BM, Laugier L, Pissetti CW, Cabantous S et al. Functional IL18 polymorphism and susceptibility to Chronic Chagas Disease. Cytokine 2015; 73: 79–83.
Costa GC, da Costa Rocha MO, Moreira PR, Menezes CA, Silva MR, Gollob KJ et al. Functional IL-10 gene polymorphism is associated with Chagas disease cardiomyopathy. J Infect Dis 2009; 199: 451–454.
Frade AF, Pissetti CW, Ianni BM, Saba B, Lin-Wang HT, Nogueira LG et al. Genetic susceptibility to Chagas disease cardiomyopathy: involvement of several genes of the innate immunity and chemokine-dependent migration pathways. BMC Infect Dis 2013; 13: 587.
Nogueira LG, Santos RH, Ianni BM, Fiorelli AI, Mairena EC, Benvenuti LA et al. Myocardial chemokine expression and intensity of myocarditis in Chagas cardiomyopathy are controlled by polymorphisms in CXCL9 and CXCL10. PLoS Negl Trop Dis 2012; 6: e1867.
Calzada JE, Beraun Y, Gonzalez CI, Martin J . Transforming growth factor beta 1 (TGFbeta1) gene polymorphisms and Chagas disease susceptibility in Peruvian and Colombian patients. Cytokine 2009; 45: 149–153.
Florez O, Zafra G, Morillo C, Martin J, Gonzalez CI . Interleukin-1 gene cluster polymorphism in chagas disease in a Colombian case-control study. Hum Immunol 2006; 67: 741–748.
Zafra G, Morillo C, Martin J, Gonzalez A, Gonzalez CI . Polymorphism in the 3′ UTR of the IL12B gene is associated with Chagas' disease cardiomyopathy. Microbes Infect 2007; 9: 1049–1052.
Zafra G, Florez O, Morillo CA, Echeverria LE, Martin J, Gonzalez CI . Polymorphisms of toll-like receptor 2 and 4 genes in Chagas disease. Mem Inst Oswaldo Cruz 2008; 103: 27–30.
Calzada JE, Nieto A, Beraun Y, Martin J . Chemokine receptor CCR5 polymorphisms and Chagas' disease cardiomyopathy. Tissue Antigens 2001; 58: 154–158.
Torres OA, Calzada JE, Beraun Y, Morillo CA, Gonzalez CI, Gonzalez A et al. Association of the macrophage migration inhibitory factor -173G/C polymorphism with Chagas disease. Hum Immunol 2009; 70: 543–546.
Torres OA, Calzada JE, Beraun Y, Morillo CA, Gonzalez A, Gonzalez CI et al. Role of the IFNG +874T/A polymorphism in Chagas disease in a Colombian population. Infect Genet Evol 2010; 10: 682–685.
Criado L, Florez O, Martin J, Gonzalez CI . Genetic polymorphisms in TNFA/TNFR2 genes and Chagas disease in a Colombian endemic population. Cytokine 2012; 57: 398–401.
Machuca MA, Suarez EU, Echeverria LE, Martin J, Gonzalez CI . SNP/haplotype associations of CCR2 and CCR5 genes with severity of chagasic cardiomyopathy. Hum Immunol 2014; 75: 1210–1215.
Florez O, Martin J, Gonzalez CI . Genetic variants in the chemokines and chemokine receptors in Chagas disease. Hum Immunol 2012; 73: 852–858.
Iwakura Y, Ishigame H, Saijo S, Nakae S . Functional specialization of interleukin-17 family members. Immunity 2011; 34: 149–162.
da Matta Guedes PM, Gutierrez FR, Maia FL, Milanezi CM, Silva GK, Pavanelli WR et al. IL-17 produced during Trypanosoma cruzi infection plays a central role in regulating parasite-induced myocarditis. PLoS Negl Trop Dis 2010; 4: e604.
Miyazaki Y, Hamano S, Wang S, Shimanoe Y, Iwakura Y, Yoshida H . IL-17 is necessary for host protection against acute-phase Trypanosoma cruzi infection. J Immunol 2010; 185: 1150–1157.
Magalhaes LM, Villani FN, Nunes Mdo C, Gollob KJ, Rocha MO, Dutra WO . High interleukin 17 expression is correlated with better cardiac function in human Chagas disease. J Infect Dis 2013; 207: 661–665.
Korn T, Bettelli E, Oukka M, Kuchroo VK . IL-17 and Th17 Cells. Annu Rev Immunol 2009; 27: 485–517.
Pitta MG, Romano A, Cabantous S, Henri S, Hammad A, Kouriba B et al. IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani. J Clin Invest 2009; 119: 2379–2387.
Nascimento MS, Carregaro V, Lima-Junior DS, Costa DL, Ryffel B, Duthie MS et al. Interleukin 17A Acts Synergistically With Interferon gamma to Promote Protection Against Leishmania infantum Infection. J Infect Dis 2015; 211: 1015–1026.
Erdmann H, Rossnagel C, Bohme J, Iwakura Y, Jacobs T, Schaible UE et al. IL-17A promotes macrophage effector mechanisms against Trypanosoma cruzi by trapping parasites in the endolysosomal compartment. Immunobiology 2013; 218: 910–923.
Ishida H, Imai T, Suzue K, Hirai M, Taniguchi T, Yoshimura A et al. IL-23 protection against Plasmodium berghei infection in mice is partially dependent on IL-17 from macrophages. Eur J Immunol 2013; 43: 2696–2706.
Kim SW, Kim ES, Moon CM, Park JJ, Kim TI, Kim WH et al. Genetic polymorphisms of IL-23R and IL-17A and novel insights into their associations with inflammatory bowel disease. Gut 2011; 60: 1527–1536.
Li N, Zhu Q, Li Z, Han Q, Zhang G, Chen J et al. IL17A gene polymorphisms, serum IL-17A and IgE levels, and hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection. Mol Carcinog 2014; 53: 447–457.
Correa JD, Madeira MF, Resende RG, Correia-Silva Jde F, Gomez RS, de Souza Dda G et al. Association between polymorphisms in interleukin-17A and -17F genes and chronic periodontal disease. Mediators Inflamm 2012; 2012: 846052.
Espinoza JL, Takami A, Nakata K, Onizuka M, Kawase T, Akiyama H et al. A genetic variant in the IL-17 promoter is functionally associated with acute graft-versus-host disease after unrelated bone marrow transplantation. PLoS One 2011; 6: e26229.
Nordang GB, Viken MK, Hollis-Moffatt JE, Merriman TR, Forre OT, Helgetveit K et al. Association analysis of the interleukin 17A gene in Caucasian rheumatoid arthritis patients from Norway and New Zealand. Rheumatology (Oxford) 2009; 48: 367–370.
Barrett JC, Fry B, Maller J, Daly MJ . Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263–265.
Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE et al. An integrated map of genetic variation from 1,092 human genomes. Nature 2012; 491: 56–65.
Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559–575.
Acknowledgements
This work is part of the doctoral thesis ‘Estudio de las bases genéticas de la enfermedad de Chagas’ from the Biomedicine PhD program at the Universidad de Granada (Spain). This work has received support from the grant nº 1102-519-29071 from the Departamento Administrativo de Ciencia, Tecnología e Innovación, Colciencias, and the Universidad Industrial de Santander, Bucaramanga, Colombia.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Leon Rodriguez, D., Echeverría, L., González, C. et al. Investigation of the role of IL17A gene variants in Chagas disease. Genes Immun 16, 536–540 (2015). https://doi.org/10.1038/gene.2015.42
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/gene.2015.42